| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 14 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Australia | 2 | |
| #4 | United States | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Herman William | 23 |
| Publication | Filing date | Title |
|---|---|---|
| US2012058048A1 | Directed radiotherapy | |
| CA2624883A1 | Directed therapy | |
| CA2441653A1 | Targeted ligands | |
| AU2003201559A1 | Multispecific binding molecules | |
| EP2075256A2 | Multispecific binding molecules | |
| CA2414148A1 | Targeted ligands | |
| CA2402930A1 | Targeted ligands | |
| CA2397169A1 | Targeted ligands | |
| CA2379586A1 | Fluid targeted ligands | |
| CA2385690A1 | Fluid targeted ligands | |
| CA2376356A1 | Targeted ligands | |
| AU2002240751A1 | Targeted ligands | |
| CA2479116A1 | Targeted ligands | |
| CA2365636A1 | Multifunctional ligand | |
| CA2357529A1 | Multifunctional ligand | |
| CA2356413A1 | Multifunctional ligand |